Filtered By:
Management: Food and Drug Administration (FDA)
Therapy: Cryotherapy
This page shows you your search results in order of date.
Order by Relevance | Date
Total 45 results found since Jan 2013.
Anti-PD1 Agents in the Treatment of Cutaneous Squamous Cell Carcinoma
Skinmed. 2022 Oct 31;20(4):338-342. eCollection 2022.ABSTRACTCutaneous squamous cell carcinoma (SCC) is the second most common type of skin cancer and accounts for approximately 25% of nonmelanoma skin cancers (NMSC). Although the majority of cutaneous SCC lesions have been treated successfully by surgical excision, cryotherapy, electrodessication, or Mohs micrographic surgery, some locally advanced SCC patients are either inoperable, have been metastasized, or both. In such patients, treatment is more challenging due to limited options. We reviewed the literature to describe the mechanism of anti-PD1 agents in cancer ther...
Source: Skinmed - October 31, 2022 Category: Dermatology Authors: Wei Niu Chelsi Robertson Deborah Hilton Source Type: research
